140 related articles for article (PubMed ID: 6807391)
1. Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.
Barrett AJ; Kendra JR; Lucas CF; Joss DV; Joshi R; Pendharkar P; Hugh-Jones K
Br Med J (Clin Res Ed); 1982 Jul; 285(6336):162-6. PubMed ID: 6807391
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
Stockschlaeder M; Storb R; Pepe M; Longton G; McDonald G; Anasetti C; Appelbaum F; Doney K; Martin P; Sullivan K
Br J Haematol; 1992 Jan; 80(1):49-54. PubMed ID: 1536809
[TBL] [Abstract][Full Text] [Related]
3. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
Storb R; Deeg HJ; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Hansen J
Br J Haematol; 1989 Aug; 72(4):567-72. PubMed ID: 2673331
[TBL] [Abstract][Full Text] [Related]
4. Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host disease.
Harper JI; Kendra JR; Desai S; Staughton RC; Barrett AJ; Hobbs JR
Br J Dermatol; 1984 Apr; 110(4):469-74. PubMed ID: 6370294
[TBL] [Abstract][Full Text] [Related]
5. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Marusić M; Francetić I; Kastelan A
Bone Marrow Transplant; 1990 Aug; 6(2):137-41. PubMed ID: 2207450
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.
Truog AW; Wozniak SP
Oncol Nurs Forum; 1990; 17(1):39-44. PubMed ID: 2405360
[TBL] [Abstract][Full Text] [Related]
7. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A and chronic graft versus host disease.
Bacigalupo A; Maiolino A; Van Lint MT; Occhini D; Gualandi F; Clavio M; Lamparelli T; Tong J; Marmon AM
Bone Marrow Transplant; 1990 Nov; 6(5):341-4. PubMed ID: 2291996
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
Bacigalupo A; Frassoni F; van Lint MT; Raffo MR; Vitale V; Corbetta G; Chierichetti S; Marmont AM
Exp Hematol; 1985 May; 13(4):244-8. PubMed ID: 3886417
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease.
Shepherd JD; Shore TB; Reece DE; Barnett MJ; Klingemann HG; Buskard NA; Phillips GL
Bone Marrow Transplant; 1988 Nov; 3(6):553-8. PubMed ID: 3063323
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.
Powles RL; Clink HM; Spence D; Morgenstern G; Watson JG; Selby PJ; Woods M; Barrett A; Jameson B; Sloane J; Lawler SD; Kay HE; Lawson D; McElwain TJ; Alexander P
Lancet; 1980 Feb; 1(8164):327-9. PubMed ID: 6101787
[TBL] [Abstract][Full Text] [Related]
12. [Cyclosporin in allogeneic bone marrow transplantation].
Klingemann HG; Storb R
Internist (Berl); 1985 Sep; 26(9):569-74. PubMed ID: 3905679
[No Abstract] [Full Text] [Related]
13. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
Storb R; Deeg HJ; Whitehead J; Farewell V; Appelbaum FR; Beatty P; Bensinger W; Buckner CD; Clift RA; Doney K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2608-13. PubMed ID: 3547942
[No Abstract] [Full Text] [Related]
14. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
Storb R; Deeg HJ; Whitehead J; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Doney K; Farewell V
N Engl J Med; 1986 Mar; 314(12):729-35. PubMed ID: 3513012
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin-A in allogeneic bone marrow transplantation for leukemia: Basle experience 1979 to 1984.
Gratwohl A
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):127-32. PubMed ID: 3914737
[TBL] [Abstract][Full Text] [Related]
16. [Cyclosporine as prophylaxis for graft versus host disease in adults undergoing allogeneic bone marrow transplantation].
Matsushita T; Akatsuka Y; Towatari M; Takeyama K; Miyamura K; Sugihara T; Minami S; Kodera Y
Rinsho Ketsueki; 1989 Apr; 30(4):429-36. PubMed ID: 2671437
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.
Aschan J; Ringdén O; Sundberg B; Gahrton G; Ljungman P; Winiarski J
Bone Marrow Transplant; 1991 Feb; 7(2):113-9. PubMed ID: 2049554
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction.
Atkinson K; Biggs JC; Britton K; Short R; Mrongovius R; Concannon A; Dodds A
Br J Haematol; 1984 Feb; 56(2):223-31. PubMed ID: 6362711
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow transplantation in leukemia and aplastic anemia].
Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
Atkinson K; Downs K; Ashby M; Biggs J
Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
